期刊文献+

结肠癌、直肠癌组织中Ki67,CK20,CEA的表达和意义 被引量:7

The expression of Ki67,CK20,CEA in colorectal carcinoma
下载PDF
导出
摘要 目的探讨结直肠癌组织中Ki67,CK20,CEA的表达与结直肠癌组织学类型,Ducks分期及分级关系。方法应有免疫组织化学方法研究60肠癌组织中Ki67,CK20和CEA的表达情况。结果癌组织CK20的表达与Ki67的关系密切,CK20表达强度随Ki67表达强度的增强而增强。不同分期及不同分化的腺癌,CK20的表达强度均有显著差异,随分期的增加或腺癌分化程度的降低,但Ki67与肿瘤的分期及分级并无相关性。CEA的血液浓度随着i67,CK20的表达增高而增高。结论 Ki67与CK20的表达和血液中的CEA浓度3者之间有很强的相关性,联合检测癌组织Ki67,CK20和血液中CEA高表达对鉴别大肠良恶性病变,提示肿瘤恶性程度高低、转移等生物学特性及预后较单独检测更有实用价值。 Objective To investigate the expression of Ki67,CK20,CEA in colorectal carcinoma,and explore the relationship with the clinical pathlogic and the Ducks stage in coloractal carcinoma.Methods The expressions of Ki67,CK20 and CEA in coloractal carcinoma in 60 patients were detected by immunohistochemical method.Results The level of the expression of Ki67 increased with the level of the expression of CK20.The expression level of CK20 was different in different grades and different differentiation stages.But the same result was not observed in Ki67.The level of the expression of CEA increased with the level of the expression of CK20 and Ki67.Conclusion There is a strong correlation in CEA,Ki67 and CK20.Detecting Ki67 combined with CK20 and CEA is more valuable to different benign or malignant colorectal lesions,pathologic grade of the tumors,metastasis and detecting them alone
出处 《实用临床医药杂志》 CAS 2011年第11期29-31,共3页 Journal of Clinical Medicine in Practice
关键词 结肠癌、直肠癌 KI67 CK20 CEA colorectal carcinoma nuclear-associated antigen ki-67 cytokeratins 20
  • 相关文献

参考文献1

二级参考文献12

  • 1M. Galindo Gallego M.D.,M. J. Fernández Ace?ero M.D.,J. Sanz Ortega M.D.,A. Aljama Delgado,J. L. Balibrea Cantero M.D.Prognostic influence of p53 nuclear overexpression in colorectal carcinoma[J].Diseases of the Colon & Rectum.2000(7)
  • 2O. Dworak,L. Keilholz,A. Hoffmann.Pathological features of rectal cancer after preoperative radiochemotherapy[J].International Journal of Colorectal Disease.1997(1)
  • 3WongNA,Brett L,Stewart M,Leitch A,Longley DB,Dunlop MG,Johnston PG,Lessells AM,Jodrell DI.Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma[].Br J Cancer.2001
  • 4HeidelbergerC,Chaudhari N,Danenberg PV.Fluorinate pyrimidines: a new class of tumor-inhibitory compounds[].Nature.1957
  • 5PopatS,Matakidou A,Houlston RS.Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis[].J Clin Oncol.2004
  • 6JakobC,Aust DE,Meyer W,Baretton GB,Schwabe W,Hausler P,Becker H,Liersch T.Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU- based neo-adjuvant chemoradiotherapy in rectal cancer[].J Pathol.2004
  • 7JakobC,Liersch T,Meyer W,Baretton GB,Hausler P,Schwabe W,Becker H,Aust DE.Immunohistochemical analysis of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer (cUICC II/III): correlation with histopathologic tumor regression after 5-fluorouracil-based long-term neoadjuvant[].Am J Surg Pathol.2005
  • 8JakobC,Liersch T,Meyer W,Baretton GB,Schwabe W,Hausler P,Kulle B,Becker H,Aust DE.Prognostic value ofhistologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy[].Am J Surg Pathol.2006
  • 9AhnenDJ,Feigl P,Quan G,Fenoglio-Preiser C,Lovato LC,Bunn PA Jr,Stemmerman G,Wells JD,Macdonald JS,Meyskens FL Jr.Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study[].Cancer Res.1998
  • 10BoyerJ,McLean EG,Aroori S,Wilson P,McCulla A,Carey PD,Longley DB,Johnston PG.Characterization of p53 wild- type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan[].Clin Cancer Res.2004

共引文献28

同被引文献65

引证文献7

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部